Cargando…

Phase I SARS vaccine trial in China

Detalles Bibliográficos
Autor principal:	Orellana, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128175/ https://www.ncbi.nlm.nih.gov/pubmed/15252932 http://dx.doi.org/10.1016/S1473-3099(04)01072-2

Ejemplares similares

Characterization of Individuals Interested in Participating in a Phase I SARS-CoV-2 Vaccine Trial
por: Shamsrizi, Parichehr, et al.
Publicado: (2021)

A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
por: Martin, Julie E., et al.
Publicado: (2008)

41P The SARS-CoV-2 vaccine and enrollment of patients with cancer in phase I trials: The experience at Institute Gustave Roussy
por: Belcaid, L., et al.
Publicado: (2022)

Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon
por: Betouke Ongwe, Madeleine Eunice, et al.
Publicado: (2022)

Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials
por: Eugenia-Toledo-Romaní, María, et al.
Publicado: (2022)

Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer
por: Coffman, Lan G., et al.
Publicado: (2022)

Phase I trial of elactocin.
por: Newlands, E. S., et al.
Publicado: (1996)

Phase I (first-in-man) prophylactic vaccine's clinical trials: Selecting a clinical trial site
por: Mehta, Shantanu, et al.
Publicado: (2015)

SARS-CoV-2 vaccination and phase 1 cancer clinical trials
por: Yap, Timothy A, et al.
Publicado: (2021)

Safety of the 15-valent pneumococcal conjugate vaccine: A phase I clinical trial
por: Pan, Lu-Lu, et al.
Publicado: (2022)

2343. SARS-CoV-2 Spike Conformation Essentially Influences Vaccine Immunogenicity – Results from Two Clinical Phase I Trials of the Vector Vaccine Candidates MVA-SARS-2-S and MVA-SARS-2-ST
por: Fathi, Anahita, et al.
Publicado: (2023)

Laboratory-acquired SARS raises worries on biosafety
por: Orellana, Claudia
Publicado: (2004)

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
por: Porter, David W., et al.
Publicado: (2011)

Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea
por: Baik, Young Ok, et al.
Publicado: (2014)

Conducting Phase I Trials During the SARS-Coronavirus-2 Outbreak: About Science and Care
por: Dipasquale, Angelo, et al.
Publicado: (2020)

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico
por: Ponce-de-León, Samuel, et al.
Publicado: (2023)

Phase I Cancer Clinical Trials
por: Ledermann, J A
Publicado: (2007)

Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma
por: Kawaguchi, Satoshi, et al.
Publicado: (2005)

Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma
por: Roehnisch, Tim, et al.
Publicado: (2014)

Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer
por: Aruga, Atsushi, et al.
Publicado: (2014)

Phase I clinical trials of safety and immunogenicity of live cultural influenza vaccine vector-flu
por: Nechaeva, Elena A, et al.
Publicado: (2015)

Analysis of the reasons for screening failure in phase I clinical trials in China: a retrospective study of the clinical trials screening process
por: Li, Bin, et al.
Publicado: (2021)

A qualitative evaluation of volunteers' experiences in a phase I/II HIV vaccine trial in Tanzania
por: Tarimo, Edith AM, et al.
Publicado: (2011)

Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
por: Ge, Chunlei, et al.
Publicado: (2017)

A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
por: Lambe, Teresa, et al.
Publicado: (2017)

A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients
por: Sato, Y, et al.
Publicado: (2004)

Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial
por: Pandey, Manisha, et al.
Publicado: (2017)

Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial
por: Rouphael, Nadine G., et al.
Publicado: (2021)

Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II
por: Piniaeva, Anastasia, et al.
Publicado: (2021)

Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin(®))
por: Singh, Chandramani, et al.
Publicado: (2023)

The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18–59 years: A phase I randomized, double-blinded, controlled trial
por: Pu, Jing, et al.
Publicado: (2021)

Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial
por: Lorentzen, Cathrine Lund, et al.
Publicado: (2022)

Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval
por: Tumban, Ebenezer
Publicado: (2020)

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
por: Phuphanich, Surasak, et al.
Publicado: (2012)

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials)
por: Rudenko, Larisa, et al.
Publicado: (2008)

Efficacy of the NCCV Cocktail‐1 vaccine for refractory pediatric solid tumors: A phase I clinical trial
por: Akazawa, Yu, et al.
Publicado: (2019)

Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial
por: Hannawi, Suad, et al.
Publicado: (2023)

Ongoing Phase I Studies of Immune Checkpoint Inhibitors in China
por: Fang, Wenfeng, et al.
Publicado: (2019)

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
por: Keech, Cheryl, et al.
Publicado: (2020)

A Review of Virus-Like Particle-Based SARS-CoV-2 Vaccines in Clinical Trial Phases
por: Sharifzadeh, Mohammad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9qrkiq7eiggniafqlnqv2jcp3d